Stereotaxis, Inc. (STXS)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 03:10PM EDT. Market open.
| Previous close | 2.1600 |
| Open | 2.1800 |
| Bid | 2.1900 x 1100 |
| Ask | 2.2000 x 1400 |
| Day's range | 2.1750 - 2.2550 |
| 52-week range | 1.3300 - 3.2900 |
| Volume | |
| Avg. volume | 332,640 |
| Market cap | 180.273M |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter
Stereotaxis (STXS) announces the regulatory submissions of its MAGiC catheter in Europe and the United States, which are intended for use in minimally invasive cardiac ablation treatments.
- Insider Monkey
Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript
Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript March 4, 2024 Stereotaxis, Inc. reports earnings inline with expectations. Reported EPS is $-0.07 EPS, expectations were $-0.07. STXS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. Thank you for […]
- Thomson Reuters StreetEvents
Q4 2023 Stereotaxis Inc Earnings Call
Q4 2023 Stereotaxis Inc Earnings Call
© 2024 Yahoo. All rights reserved.